With the ageing population, the proportion of older drivers on the road is also increasing. In many countries such as Canada, the USA, and Australia, driving is essential for daily activities among older adults [
1,
2]. Specifically, driving can contribute to older adults’ quality of life by supporting their independence, autonomy, and access to a variety of services [
3]. Given that age is the most important risk factor for Alzheimer’s disease (AD), it is anticipated that the number of drivers with AD will continue to grow. Individuals at the early symptomatic stages may be able to safely drive [
4]. However, AD will eventually impact the fitness to drive, and people at later stages of AD have to eventually stop driving [
5‐
7]. Studies have shown that older drivers with mild to moderate AD are at a 2 to 8 times higher risk of crashes compared to age-matched controls [
8,
9]. Additionally, due to navigational deficits, people with AD may become disoriented in different environments and face difficulty finding their way even in familiar environments [
10,
11]. While driving, these individuals may forget where they intended to go, not recognize their neighbourhood streets and landmarks, and consequently become lost [
12]. Becoming lost may have serious consequences and can place drivers at greater risk of injury and even death [
12,
13]. To date, many studies have investigated the interconnectedness between symptomatic AD and driving. Less attention has been paid to changes in driving in the preclinical stage of AD, which occurs in individuals with evidence of AD pathology who have no clinical symptoms. This mini-review summarizes what is known to date about preclinical AD and driving.